Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: ACUTE CORONARY SYNDROME - DRUG THERAPY , . Treffer: 8
2019
Freynhofer, MK; Hein-Rothweiler, R; Haller, PM; Aradi, D; Dézsi, DA; Gross, L; Orban, M; Trenk, D; Geisler, T; Huczek, Z; Toth-Gayor, GG; Massberg, S; Huber, K; Sibbing, D
Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
Thromb Haemost. 2019; 119(4):660-667
Doi: 10.1055/s-0038-1677549
Web of Science
PubMed
FullText
FullText_MUG
Tomaniak, M; Chichareon, P; Onuma, Y; Deliargyris, EN; Takahashi, K; Kogame, N; Modolo, R; Chang, CC; Rademaker-Havinga, T; Storey, RF; Dangas, GD; Bhatt, DL; Angiolillo, DJ; Hamm, C; Valgimigli, M; Windecker, S; Steg, PG; Vranckx, P; Serruys, PW; GLOBAL LEADERS Trial Investigators
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
JAMA Cardiol. 2019; 4(11):1092-1101
Doi: 10.1001/jamacardio.2019.3355
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Winter, MP; von Lewinski, D; Wallner, M; Prüller, F; Kolesnik, E; Hengstenberg, C; Siller-Matula, JM
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study.
Sci Rep. 2019; 9(1):8194-8194
Doi: 10.1038/s41598-019-44673-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Tscharre, M; Egger, F; Machata, M; Rohla, M; Michael, N; Neumayr, M; Zweiker, R; Hajos, J; Adlbrecht, C; Suppan, M; Helmreich, W; Eber, B; Huber, K; Weiss, TW
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
PLoS One. 2017; 12(6):e0179349-e0179349
Doi: 10.1371/journal.pone.0179349
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Stachon, P; Ahrens, I; Bode, C; Zirlik, A
Dual pathway therapy in acute coronary syndrome.
J THROMB THROMBOLYS. 2016; 42(2): 254-260.
Doi: 10.1007/s11239-015-1306-3
Web of Science
PubMed
FullText
FullText_MUG
2015
Silbernagel, G; Baumgartner, I; März, W
Ezetimibe plus a Statin after Acute Coronary Syndromes.
N Engl J Med. 2015; 373(15):1473-1473
Doi: 10.1056/NEJMc1509363#SA1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Ahrens, I; Bode, C; Zirlik, A
Anticoagulation during and after acute coronary syndrome.
HAMOSTASEOLOGIE. 2014; 34(1): 72-77.
Doi: 10.5482/HAMO-13-09-0048
Web of Science
PubMed
FullText
FullText_MUG
2008
von Lewinski, F; Riggert, J; Paulus, W
Prasugrel versus clopidogrel.
N Engl J Med. 2008; 358(12):1299; author reply 1299-1299; author reply 1301
Doi: 10.1056/NEJMc073398
Web of Science
PubMed
FullText
FullText_MUG